DC Field | Value | Language |
---|---|---|
dc.contributor.author | Won Kon Kim | - |
dc.contributor.author | Kwang-Hee Bae | - |
dc.contributor.author | Sang Chul Lee | - |
dc.contributor.author | Kyoung-Jin Oh | - |
dc.date.accessioned | 2020-02-07T16:30:21Z | - |
dc.date.available | 2020-02-07T16:30:21Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | 10.3390/jcm8111874 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/19104 | - |
dc.description.abstract | The Special Issue "Pathogenetic and Therapeutic Significance of Adipokines in Diabetes" focused on adipokines as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes. Experts discussed the pathological role of adipokines in their studies associated with diabetes. It provided new insights into the role of adipokines in diabetes. In this commentary and review, these studies will be summarized and the novel roles of adipokines will be discussed. This will also confirm the role of adipokines as biomarkers for diagnosis and prediction, and as therapeutic targets of diabetes and its related pathogenic phenomena | - |
dc.publisher | MDPI | - |
dc.title | The latest insights into adipokines in diabetes | - |
dc.title.alternative | The latest insights into adipokines in diabetes | - |
dc.type | Article | - |
dc.citation.title | Journal of Clinical Medicine | - |
dc.citation.number | 11 | - |
dc.citation.endPage | 1874 | - |
dc.citation.startPage | 1874 | - |
dc.citation.volume | 8 | - |
dc.contributor.affiliatedAuthor | Won Kon Kim | - |
dc.contributor.affiliatedAuthor | Kwang-Hee Bae | - |
dc.contributor.affiliatedAuthor | Sang Chul Lee | - |
dc.contributor.affiliatedAuthor | Kyoung-Jin Oh | - |
dc.contributor.alternativeName | 김원곤 | - |
dc.contributor.alternativeName | 배광희 | - |
dc.contributor.alternativeName | 이상철 | - |
dc.contributor.alternativeName | 오경진 | - |
dc.identifier.bibliographicCitation | Journal of Clinical Medicine, vol. 8, no. 11, pp. 1874-1874 | - |
dc.identifier.doi | 10.3390/jcm8111874 | - |
dc.subject.keyword | adipokines | - |
dc.subject.keyword | biomarkers | - |
dc.subject.keyword | diabetes | - |
dc.subject.keyword | diagnosis | - |
dc.subject.keyword | prediction | - |
dc.subject.keyword | therapeutic targets | - |
dc.subject.local | adipokine | - |
dc.subject.local | adipokines | - |
dc.subject.local | Adipokines | - |
dc.subject.local | biomarkers | - |
dc.subject.local | Diabetes | - |
dc.subject.local | diabetes | - |
dc.subject.local | diagnosis | - |
dc.subject.local | Diagnosis | - |
dc.subject.local | Prediction | - |
dc.subject.local | prediction | - |
dc.subject.local | Therapeutic Targets | - |
dc.subject.local | therapeutic target | - |
dc.subject.local | therapeutic targets | - |
dc.subject.local | Therapeutic target | - |
dc.subject.local | Therapeutic targets | - |
dc.description.journalClass | Y | - |
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.